New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 15, 2012
10:06 EDTSAFM, CTIC, TRLA, TRN, NOW, OMER, NBHC, KEYW, GAIN, TRAK, CBFOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Capital Bank (CBF) initiated with a Market Perform at Keefe Bruyette... Capital Bank (CBF) initiated with a Neutral at Goldman... DealerTrack (TRAK) initiated with an Overweight at Evercore... Gladstone Investment (GAIN) initiated with a Buy at Jefferies... KEYW (KEYW) initiated with an Outperform at RBC Capital... National Bank (NBHC) initiated with an Outperform at Keefe Bruyette... Omeros (OMER) initiated with an Outperform at Burrill... ServiceNow (NOW) initiated with an Equal Weight at Evercore... Trinity Industries (TRN) initiated with a Buy at UBS... Trulia (TRLA) initiated with a Neutral at JPMorgan... Trulia (TRLA) initiated with an Outperform at RBC Capital... Trulia (TRLA) initiated with a Buy at Needham... Cell Therapeutics (CTIC) initiated with a Buy at ThinkEquity... Sanderson Farms (SAFM) initiated with a Buy at Sidoti.
News For CBF;TRAK;GAIN;KEYW;NBHC;OMER;NOW;TRN;TRLA;CTIC;SAFM From The Last 14 Days
Check below for free stories on CBF;TRAK;GAIN;KEYW;NBHC;OMER;NOW;TRN;TRLA;CTIC;SAFM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 24, 2014
06:07 EDTCBFCapital Bank reports Q2 EPS 25c, consensus 25c
Subscribe for More Information
July 23, 2014
11:18 EDTTRNDoT proposes phase out of older DOT 111 tank cars for certain flammable liquids
Subscribe for More Information
July 22, 2014
07:17 EDTTRLANational Association for Business Economics to hold a seminar
Subscribe for More Information
July 21, 2014
05:12 EDTCTICCTI BioPharma announces approval of Pixuvri in Israel
CTI BioPharma announced that it has received approval from the Israeli Ministry of Health, or MOH, for Pixuvri. Pixuvri in Israel is indicated as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma who have received not more than three previous courses of treatment. The benefit of pixantrone treatment has not been established in patients when used as fifth line or greater chemotherapy in patients who are refractory to last therapy. In Israel, Pixuvri will be distributed and marketed by the Neopharm Group, Israel's second largest pharmaceuticals and health products marketer, once Pixuvri is included in the Israeli National Health Basket of drugs by the MOH. Separately, the Dutch Healthcare Authority, or NZa, and the healthcare insurance board College voor zorgverzekeringen, or CVZ, of the Netherlands have approved funding for Pixuvri as an add-on drug for patients who need a third- or fourth-line treatment option for aggressive B-cell lymphoma. This follows the inclusion of Pixuvri on the HOVON, or Haemato Oncology Foundation for Adults in the Netherlands, treatment guidelines, effective June 1. The inclusion on the Dutch list of reimbursed drugs makes Pixuvri the first registered and reimbursed medicine for the treatment of patients with multiply relapsed or refractory aggressive B-cell NHL in the Netherlands.
July 18, 2014
12:48 EDTTRLARealPage tumbles after reporting preliminary Q2 revenue miss
Subscribe for More Information
July 17, 2014
16:11 EDTNBHCNational Bank approves new $50M stock repurchase program
Subscribe for More Information
July 15, 2014
16:22 EDTKEYWKEYW reports Q2 revenue $72.5M-$74.5M, consensus $72.56M
Subscribe for More Information
16:19 EDTKEYWKEYW files to sell $125M of new senior convertible notes due 2019
Subscribe for More Information
July 11, 2014
09:01 EDTTRLATrulia says 54M unique visitors visited site in June
Subscribe for More Information
08:06 EDTNOWServiceNow shares should be bought ahead of earnings, says Pacific Crest
Subscribe for More Information
July 10, 2014
16:15 EDTKEYWKEYW, Oracle collaborate on advanced security solutions
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use